Back to Blog Joint Health

Mounjaro, Fat Loss, and Joint Pain: How Weight-Loss Drugs Transform Orthopaedic Health

LSRI 12 March 2026 4 min read
Mounjaro, Fat Loss, and Joint Pain: How Weight-Loss Drugs Transform Orthopaedic Health

The medical community is experiencing a paradigm shift. For decades, knee and hip pain—especially osteoarthritis (OA)—were viewed as strictly mechanical wear-and-tear problems. If a patient was overweight, the advice was universally, “You need to lose weight to take pressure off the joint.” Yet, for a patient in chronic pain, exercising for fat loss is often agonising or physically impossible. This creates a debilitating cycle.

Today, breakthrough weight-loss medications known as GLP-1 and GIP agonists (most notably Mounjaro, Wegovy, and Ozempic) are fundamentally altering this dynamic. Dr Prashant Sankaye, Consultant MSK Radiologist and Clinical Director at London Sports & Rheumatology Imaging, explains how these medications are offering unprecedented hope for patients struggling with obesity and severe joint pain.

How Excess Fat Drives Joint Degeneration

Before understanding the cure, we must understand the cause. Being overweight affects your joints in two distinct ways:

  1. Mechanical Stress: Every pound of excess body weight places roughly four pounds of extra pressure on your knees with every single step. Stripping away just 10 pounds of body fat removes 40 pounds of chronic mechanical stress from your knee cartilage.
  2. Systemic Inflammation: This is often the hidden culprit. Adipose tissue (body fat) is not inert; it is hormonally active. Fat cells continuously release inflammatory cytokines into your bloodstream. This systemic inflammation literally accelerates the chemical breakdown of the cartilage inside your joints. This is known clinically as Metabolic Osteoarthritis.

The Mounjaro Advantage: Rapid Fat Loss and Anti-Inflammatory Power

Medications like Mounjaro (tirzepatide) induce massive weight loss by mimicking hormones that regulate blood sugar and intensely suppress appetite. As patients rapidly shed body fat, two incredible things happen simultaneously for their orthopaedic health:

1. The “Mechanical Unloading”

Patients on these medications frequently lose 15-20% of their total body weight within the first year. “The relief experienced by simply unloading the joint mechanically is profound,” notes Dr Prashant Sankaye. “Patients who could barely walk are suddenly able to engage in vital physiotherapy and light exercise, reversing the cycle of muscular atrophy.”

2. Dousing the Inflammatory Fire

Because weight-loss drugs drastically reduce visceral fat, the volume of inflammatory markers circulating in the body plummets. This means the systemic inflammation that was actively eating away at the joint stops. The knee is no longer constantly swollen and achy.

The Bridge to Definitive Treatment at LSRI

While Mounjaro and other weight-loss drugs can completely change your metabolic profile, the cartilage damage that has already occurred in the joint will not magically regrow. You must still actively manage the osteoarthritis.

This is where precision MSK care becomes paramount. Losing weight makes targeted orthopaedic treatments significantly more effective. Dr Prashant Sankaye routinely partners with patients who have achieved significant fat loss to provide definitive local treatments:

  • Precision Diagnosis: Has the cartilage degraded? Dr Sankaye utilises advanced 3T MRI scanning to accurately map the remaining cartilage after major weight loss.
  • Viscosupplementation: For patients wanting to preserve their joints long-term and avoid surgery, Arthrosamid®—a permanent, non-biodegradable hydrogel injected directly into the knee under ultrasound guidance—provides the perfect protective scaffold. Reduced body weight means the implant endures far less stress, maximising its longevity.
  • Regenerative Medicine: PRP (Platelet-Rich Plasma) injections are proven to stimulate natural tissue healing, made far more potent when operating in a body with lower systemic inflammation.

“Fat loss via medications like Mounjaro acts as the ultimate primer. Once the systemic inflammation is under control and the load is reduced, our ultrasound-guided therapeutic injections have the ideal environment to deliver remarkable, long-lasting pain relief.” — Dr Prashant Sankaye

The Verdict

Weight-loss medications are not just cosmetic; they are a powerful, proactive treatment for joint preservation. If you are on a fat-loss journey and want to definitively heal your joint pain, expert imaging and precision injections are your next step. Book a consultation with Dr Prashant Sankaye today at London Sports & Rheumatology Imaging.

Dr Prashant Sankaye

About the Author: Dr Prashant Sankaye

Dr Prashant Sankaye is a highly respected Consultant MSK Radiologist and the Clinical Director of London Sports & Rheumatology Imaging (LSRI). With over a decade of sub-specialty experience, he is a recognized expert in advanced diagnostic imaging (Ultrasound & 3T MRI) and precision ultrasound-guided therapeutic injections. His authoritative approach ensures patients avoid surgery where possible and receive the highest standard of orthopaedic, rheumatological, and sports medicine care.

Verified Medical Expert E-E-A-T Certified

Related Articles

Need Expert Medical Advice?

Book a consultation with our specialist team for personalised guidance on your condition.

Book Appointment
Chat with us on WhatsApp